Dr Sara Farrah Heuss

Postdoctoral Researcher
Research Focus

C-Met is a receptor tyrosine kinase, overexpressed in pancreatic cancer. Studies published by our group have shown that c-Met triggers the activation of oncogenic signals such as ERK1/2, STAT3 and Rac1 from endosomes. My work focuses on c-Met signalling on endosomes in pancreatic cancer, and to evaluate how it can be exploited to benefit pancreatic cancer patients.

Dr St├ęphanie Kermorgant